Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Health Group ( (HK:0673) ) just unveiled an announcement.
China Health Group Limited reported its unaudited condensed consolidated interim financial results for the six months ending September 30, 2025. The company experienced a slight increase in revenue to HK$19,610,000 from HK$18,680,000 in the previous year. However, it faced a loss before tax of HK$10,889,000, which is an improvement from the previous year’s loss of HK$17,607,000. The total comprehensive loss for the period was HK$10,648,000, showing a reduction from the previous year’s loss of HK$18,130,000. Despite the losses, the financial results indicate a narrowing of losses, which could suggest potential stabilization or improvement in the company’s financial health.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
China Health Group Limited, operating in Hong Kong as CHG HS Limited, is incorporated in Bermuda with limited liability. The company is involved in the healthcare industry, focusing on providing health-related services and products.
Average Trading Volume: 831,133
Technical Sentiment Signal: Buy
Current Market Cap: HK$830.3M
See more data about 0673 stock on TipRanks’ Stock Analysis page.